This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

TPCO Holding Valuation

Is 6XZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6XZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 6XZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 6XZ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6XZ?

Key metric: As 6XZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6XZ. This is calculated by dividing 6XZ's market cap by their current revenue.
What is 6XZ's PS Ratio?
PS Ratio	0.2x
Sales	US$79.25m
Market Cap	US$19.07m

6XZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.05x
Enterprise Value/EBITDA	-0.05x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 6XZ's PS Ratio compare to its peers?

The above table shows the PS ratio for 6XZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3.8x
A123330 Genic	4.3x	n/a	₩123.7b
CRL Creightons	0.4x	n/a	UK£23.3m
PAVS Paranovus Entertainment Technology	9.4x	n/a	US$61.6m
A025620 Jayjun Cosmetic	1x	n/a	₩20.2b
6XZ TPCO Holding	0.2x	-3.4%	€19.1m

Price-To-Sales vs Peers: 6XZ is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.7x).

Price to Sales Ratio vs Industry

How does 6XZ's PS Ratio compare vs other companies in the European Personal Products Industry?

9 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.7x	4.6%
6XZ TPCO Holding	0.2x	-3.4%	US$19.07m

9 Companies		Estimated Growth	Market Cap
Industry Avg.	1.7x	8.0%
6XZ TPCO Holding	0.2x	n/a	US$19.07m

No more companies

Price-To-Sales vs Industry: 6XZ is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Personal Products industry average (1.2x)

Price to Sales Ratio vs Fair Ratio

What is 6XZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6XZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	0.1x

Price-To-Sales vs Fair Ratio: 6XZ is expensive based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6XZ forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Nov ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Oct ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Sep ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Aug ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Jul ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Jun ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
May ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Apr ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Mar ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Feb ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Jan ’25	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Dec ’24	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Nov ’24	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Oct ’24	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Sep ’24	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Aug ’24	n/a	€0.35 0%	55.8%	€0.54	€0.15	n/a	2
Jul ’24	€0.15	€0.35 +138.8%	55.8%	€0.54	€0.15	n/a	2
Jun ’24	€0.14	€0.35 +152.6%	55.8%	€0.54	€0.15	n/a	2
May ’24	€0.17	€0.35 +110.0%	55.8%	€0.54	€0.15	n/a	2
Apr ’24	€0.13	€0.64 +375.1%	48.1%	€0.94	€0.33	n/a	2
Mar ’24	€0.25	€0.64 +158.8%	48.1%	€0.94	€0.33	n/a	2
Feb ’24	€0.26	€0.65 +152.7%	48.1%	€0.97	€0.34	n/a	2
Jan ’24	€0.13	€0.65 +390.2%	48.1%	€0.97	€0.34	n/a	2
Dec ’23	€0.21	€0.65 +207.5%	48.1%	€0.97	€0.34	n/a	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Cheerwin Group

HK$2.5b

An investment holding company, manufactures and trades household insecticides and repellents, household cleaning, air care, personal care, pets and pet products, and other products in the People’s Republic of China.

1RQ

HK$0.22

3.8%

36.3%

Revolution Beauty Group

UK£39.7m

Engages in the development, production, wholesale, and retail of beauty products in the United Kingdom, the United States, and internationally.

8UA

UK£0.14

-4.0%

-62.3%

L'Oréal

€175.8b

Through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide.

LOR

€327.85

-0.6%

-24.9%